Page last updated: 2024-12-08

4-nitrocatechol sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-nitrocatechol sulfate: RN given refers to 2-sulfate moiety locant [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-hydroxy-5-nitrophenyl hydrogen sulfate : An aryl sulfate that is 4-nitrocatechol in which the hydroxy group that is meta to the nitro group has been converted into the corresponding hydrogen sulfate. It is used (commonly as its dipotassium salt) as a chromogenic substrate for sulphatase. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID165879
CHEBI ID41733
SCHEMBL ID4308319
MeSH IDM0075821

Synonyms (26)

Synonym
4-nitro-1,2-benzenediol, 2-(hydrogen sulfate)
10485-66-2
CSN ,
n,4-dihydroxy-n-oxo-3-(sulfooxy)benzenaminium
1PA9
2-hydroxy-5-nitrophenyl sulfate
p-nitrocatechol sulfate
4-nitrocatechol sulfate
2-hydroxy-5-nitrophenyl hydrogen sulfate
DB01800
para-nitrocatechol sulfate
hd9mhq536a ,
unii-hd9mhq536a
(2-hydroxy-5-nitrophenyl)oxidanesulfonic acid
1,2-benzenediol, 4-nitro-, 2-(hydrogen sulfate)
4-nitrocatechol 2-sulfate
nitrocatechol sulfate, p-
pyrocatechol, 4-nitro-, 2-(hydrogen sulfate)
5-nitrocatechol sulfate
SCHEMBL4308319
CHEBI:41733
sulfuric acid mono-(2-hydroxy-5-nitro-phenyl ester)
DTXSID50146785
Q27092941
EN300-26678052
PD008416
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
chromogenic compoundColourless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into coloured compounds. They are used in biochemical assays and in diagnosis as indicators, particularly in the form of enzyme substrates.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
4-nitrophenolsA mononitrophenol that is 4-nitrophenol and its derivatives resulting from substitution of one or more of the hydrogens attached to the benzene ring by a non-nitro group.
aryl sulfate
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Protein-tyrosine phosphatase yopHYersinia enterocoliticaKi25.000025.000025.000025.0000AID977610
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB2003The Journal of biological chemistry, Aug-29, Volume: 278, Issue:35
Crystal structure of the Yersinia protein-tyrosine phosphatase YopH complexed with a specific small molecule inhibitor.
AID1811Experimentally measured binding affinity data derived from PDB2003The Journal of biological chemistry, Aug-29, Volume: 278, Issue:35
Crystal structure of the Yersinia protein-tyrosine phosphatase YopH complexed with a specific small molecule inhibitor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (50.00)18.7374
1990's3 (11.54)18.2507
2000's6 (23.08)29.6817
2010's4 (15.38)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.97 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index19.78 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies3 (11.54%)4.05%
Observational0 (0.00%)0.25%
Other23 (88.46%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]